Humana’s shares surged after the company disclosed select details from the government’s Star Ratings for its 2026 Medicare Advantage plans. The market responded swiftly, reflecting investor optimism about the insurer’s potential performance.

In a significant move for patients, major health insurers are pledging to improve coverage reviews that have long caused delays and complaints.